Abstract:Ischemic stroke (IS) characterized with high morbidity and mortality rates is considered as one of the most dangerous brain diseases. The timely assessment of IS is crucial for making a clinical decision due to the severity of IS featured with time-dependence. Herein, we develop a highly reactive oxygen species (HROS)-responsive ratiometric near-infrared-II (NIR-II) nanoprobe based on a dye-sensitized system between IR-783 dye and lanthanide-doped nanoparticles. Once intravenously injected into the mice, the probe is rapidly accumulated at a lesion site by recognizing the activated endothelial cell or impaired blood–brain barrier (BBB) in the ischemic area and further responds to HROS, thereby allowing in vivo imaging of the oxidative stress level. The probe is not only able to discriminate the salvageable ischemic tissue from infarcted stroke core by visualizing the enriched degree of the probe at the lesion site but also can grade the salvageable ischemic tissue by analyzing the oxidative stress level. In addition, the ischemia area was clearly delineated by NIR-II luminescence imaging after cerebral ischemia for 30 min, which is significantly earlier than with the magnetic resonance imaging (MRI) method, thereby providing a practical tool for the timely assessing of IS.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsnano.1c03117?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsnano.1c03117</a>.Discussions of materials and instrumentation used and figures of size distribution histograms, linear relationship between absorbance and concentration, fluorescence emission spectra, FTIR spectra, UV–vis absorption spectra, δ potentials, TEM image, change of hydrodynamic diameter, ratiometric responses of IR-LnNPs, DCL intensity, viability of mouse brain microvascular endothelial cells, blood biochemical analysis of the mice with or without IR-LnNPs treatment, H&E staining of major organs, NIR-II luminescence and ratiometric images, upconversion luminescence spectrum, confocal images, in vivo NIR-II luminescence imaging, representative MR images, normalized MR signal intensities, blood sugar levels, and change of superoxide dismutase and lipid peroxidation levels (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.1c03117/suppl_file/nn1c03117_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

A non-invasive nanoparticles for multimodal imaging of ischemic myocardium in rats

A non-invasive osteopontin-targeted phase changeable fluorescent nanoprobe for molecular imaging of myocardial fibrosis

Photoacoustic Imaging of Myocardial Infarction Region Using Non-Invasive Fibrin-Targeted Nanoparticles in a Rat Myocardial Ischemia-Reperfusion Model

A Novel Ultrasound‐Responsive Biomimetic Nanoparticle for Targeted Delivery and Controlled Release of Nitric Oxide to Attenuate Myocardial Ischemia Reperfusion Injury

Collagen-Targeting Self-Assembled Nanoprobes for Multimodal Molecular Imaging and Quantification of Myocardial Fibrosis in a Rat Model of Myocardial Infarction

Multimodal SPION-CREKA Peptide Based Agents for Molecular Imaging of Microthrombus in a Rat Myocardial Ischemia-Reperfusion Model

Multimodal and Multifunctional Nanoparticles with Platelet Targeting Ability and Phase Transition Efficiency for the Molecular Imaging and Thrombolysis of Coronary Microthrombi.

Construction of CNA35 Collagen-Targeted Phase-Changeable Nanoagents for Low-Intensity Focused Ultrasound-Triggered Ultrasound Molecular Imaging of Myocardial Fibrosis in Rabbits

Targeted Myocardial Hypoxia Imaging Using a Nitroreductase-Activatable Near-Infrared Fluorescent Nanoprobe

Visualizing Oxidative Stress Level for Timely Assessment of Ischemic Stroke via a Ratiometric Near-Infrared-II Luminescent Nanoprobe

Macrophage membrane-modified targeted phase-change nanoparticles for multimodal imaging of experimental autoimmune myocarditis

Ultra-Early Diagnosis of Acute Myocardial Infarction in Rats Using Ultrasound Imaging of Hollow Double-Layer Silica Nanospheres

Construction of dual nanomedicines for the imaging and alleviation of atherosclerosis

Multimodality Molecular Imaging of Cardiovascular Disease Based on Nanoprobes

Timely Visualization of the Collaterals Formed during Acute Ischemic Stroke with Fe 3 O 4 Nanoparticle-based MR Imaging Probe.

Recent advances in nanomedicines for imaging and therapy of myocardial ischemia-reperfusion injury

A Neutrophil-Mimetic Magnetic Nanoprobe for Molecular Magnetic Resonance Imaging of Stroke-Induced Neuroinflammation

A Minimalist Iron Oxide Nanoprobe for the High-Resolution Depiction of Stroke by Susceptibility-Weighted Imaging

New diagnostic and therapeutic strategies for myocardial infarction via nanomaterials

Instantaneous in Vivo Imaging of Acute Myocardial Infarct by NIR‐II Luminescent Nanodots

Real-Time Visualization of the Antioxidative Potency of Drugs for the Prevention of Myocardium Ischemia-Reperfusion Injury by a NIR Fluorescent Nanoprobe.